Answers are grounded in this paper and cite their sources.
Aim: This study aims to explore the clinical utility of intranasal medications in emergency care, with a comparison to other administration routes. Material and Methods: A search of PubMed on March 12, 2025, retrieving 55 articles from 2020-2025. Studies published in English between 2020 and 2025, along with select relevant publications from earlier years, were included. Ultimately, 38 articles met our inclusion criteria. All authors reviewed and revised the final manuscript. Intranasal therapies are quick, easy to use, and effective in emergencies like pain, seizures, and overdoses. Analgesics such as fentanyl, ketamine, and sufen¬tanil show efficacy comparable to intravenous opioids. Intranasal naloxone and nalmefene improve access in overdose emergencies, while nasal midazolam and diazepam are effective and well-tolerated for seizure control. FMXIN002 demonstrates potential for anaphylaxis treatment. Despite advances in the use of intranasal drugs, challenges remain. Continued innovation may lead to entirely new therapeutic possibilities. Conclusions: Intranasal drug administration is increasingly recognized as a practical and non-invasive alternative method, particularly in scenarios requiring rapid therapeutic action. This route is especially advantageous in pediatric populations due to ease of use and patient compliance.
No takes yet. Share an insight, caveat, or question.
Ochman-Pasierbek et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: